These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
221 related articles for article (PubMed ID: 8890047)
21. Prevalence and clinical significance of HGV/GBV-C infection in patients with chronic hepatitis B or C. Yang JF; Dai CY; Chuang WL; Lin WY; Lin ZY; Chen SC; Hsieh MY; Wang LY; Tsai JF; Chang WY; Yu ML Jpn J Infect Dis; 2006 Feb; 59(1):25-30. PubMed ID: 16495630 [TBL] [Abstract][Full Text] [Related]
22. Prevalence and genotypic distribution of hepatitis GB-C/HG and TT viruses in blood donors, mentally retarded children and four groups of patients in eastern Anatolia, Turkey. Kalkan A; Ozdarendeli A; Bulut Y; Saral Y; Ozden M; Keleştimur N; Toraman ZA Jpn J Infect Dis; 2005 Aug; 58(4):222-7. PubMed ID: 16116255 [TBL] [Abstract][Full Text] [Related]
23. Hepatitis GBV-C infection in intravenous drug users. Vimolket T; Theamboonlers A; Tangkijvanich P; Poovorawan Y Southeast Asian J Trop Med Public Health; 1998 Sep; 29(3):491-6. PubMed ID: 10437944 [TBL] [Abstract][Full Text] [Related]
24. Prevalence of GB virus C (hepatitis G virus) and risk factors for infection in São Paulo, Brazil. Ribeiro-dos-Santos G; Nishiya AS; Nascimento CM; Bassit L; Chamone DF; Focaccia R; Eluf-Neto J; Sabino EC Eur J Clin Microbiol Infect Dis; 2002 Jun; 21(6):438-43. PubMed ID: 12111599 [TBL] [Abstract][Full Text] [Related]
25. Detection of GBV-C RNA in patients with non-A-E fulminant hepatitis by reverse-transcription polymerase chain reaction. Kanda T; Yokosuka O; Ehata T; Maru Y; Imazeki F; Saisho H; Shiratori Y; Omata M Hepatology; 1997 May; 25(5):1261-5. PubMed ID: 9141449 [TBL] [Abstract][Full Text] [Related]
27. Genetic heterogeneity and molecular epidemiology of GB virus C/hepatitis G virus in China. An P; Luo H; Lu T; O'Brien SJ; Winkler C J Hum Virol; 2000; 3(6):299-305. PubMed ID: 11100910 [TBL] [Abstract][Full Text] [Related]
28. Prevalence of GB virus C/hepatitis G virus infection in pediatric patients receiving multiple transfusions in Southern Turkey. Kocabaş E; Antmen B; Yarkin F; Serin M; Aksungur P; Tanyeli A; Kilinç Y; Aksaray N Turk J Pediatr; 1999; 41(1):81-90. PubMed ID: 10770680 [TBL] [Abstract][Full Text] [Related]
29. No association between hepatitis C and B-cell lymphoma. Collier JD; Zanke B; Moore M; Kessler G; Krajden M; Shepherd F; Heathcote J Hepatology; 1999 Apr; 29(4):1259-61. PubMed ID: 10094973 [TBL] [Abstract][Full Text] [Related]
30. Infection with GB virus C (GBV-C) in patients with chronic liver disease or on maintenance hemodialysis in Indonesia. Tsuda F; Hadiwandowo S; Sawada N; Fukuda M; Tanaka T; Okamoto H; Miyakawa Y; Mayumi M J Med Virol; 1996 Jul; 49(3):248-52. PubMed ID: 8818973 [TBL] [Abstract][Full Text] [Related]
31. Association between fulminant hepatic failure and a strain of GBV virus C. Heringlake S; Osterkamp S; Trautwein C; Tillmann HL; Böker K; Muerhoff S; Mushahwar IK; Hunsmann G; Manns MP Lancet; 1996 Dec; 348(9042):1626-9. PubMed ID: 8961994 [TBL] [Abstract][Full Text] [Related]
32. Prevalence, implication, and viral nucleotide sequence analysis of GB virus-C/hepatitis G virus infection in acute fulminant and nonfulminant hepatitis. Wu JC; Chiang TY; Huang YH; Huo TI; Hwang SJ; Huang IS; Sheng WY; Lee SD J Med Virol; 1998 Oct; 56(2):118-22. PubMed ID: 9746066 [TBL] [Abstract][Full Text] [Related]
33. [Causal relationship between GBV-C and fulminant hepatitis]. Inoue K; Yoshiba M; Sekiyama K Nihon Rinsho; 1997 Mar; 55(3):578-82. PubMed ID: 9086761 [TBL] [Abstract][Full Text] [Related]
34. Identification of antigenic regions in the GB hepatitis viruses GBV-A, GBV-B, and GBV-C. Pilot-Matias TJ; Muerhoff AS; Simons JN; Leary TP; Buijk SL; Chalmers ML; Erker JC; Dawson GJ; Desai SM; Mushahwar IK J Med Virol; 1996 Apr; 48(4):329-38. PubMed ID: 8699165 [TBL] [Abstract][Full Text] [Related]
36. GB virus C (GBV-C) infection in patients with chronic hepatitis C. Influence on liver disease and on hepatitis virus behaviour: effect of interferon alfa therapy. Pawlotsky JM; Roudot-Thoraval F; Muerhoff AS; Pellerin M; Germanidis G; Desai SM; Bastie A; Darthuy F; Rémiré J; Zafrani ES; Soussy CJ; Mushahwar IK; Dhumeaux D J Med Virol; 1998 Jan; 54(1):26-37. PubMed ID: 9443106 [TBL] [Abstract][Full Text] [Related]
37. The clinical significance of the detection of hepatitis GBV-C RNA in the serum of patients with fulminant, presumed viral, hepatitis. Haydon GH; Jarvis LM; Simpson KJ; Hayes PC; Simmonds P J Viral Hepat; 1997 Jan; 4(1):45-9. PubMed ID: 9031064 [TBL] [Abstract][Full Text] [Related]
38. Exposure to GB virus type C or hepatitis G virus in selected Australian adult and children populations. Hyland CA; Mison L; Solomon N; Cockerill J; Wang L; Hunt J; Selvey LA; Faoagali J; Cooksley WG; Young IF; Trowbridge R; Borthwick I; Gowans EJ Transfusion; 1998 Sep; 38(9):821-7. PubMed ID: 9738621 [TBL] [Abstract][Full Text] [Related]
39. GB virus type C viremia and envelope antibodies among population subsets in The Netherlands. Jongerius J; Boland G; van der Poel C; Rasch M; Italiaander E; van der Reijden J; Friedman P; Cockerill J; van Leeuwen E; van Hattum J Vox Sang; 1999; 76(2):81-4. PubMed ID: 10085523 [TBL] [Abstract][Full Text] [Related]
40. Infection with GB virus C and hepatitis C virus in drug addicts, patients on maintenance hemodialysis, or with chronic liver disease in Nepal. Shrestha SM; Shrestha S; Tsuda F; Sawada N; Tanaka T; Okamoto H; Miyakawa Y; Mayumi M J Med Virol; 1997 Oct; 53(2):157-61. PubMed ID: 9334927 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]